Investigação portuguesa marca presença no ESMO 2025

17 de outubro:

14h00 – 15h15 | Cologne Auditorium, citycube A | “The Role of Surgery”, Maria João Cardoso, Fundação Champalimaud, Lisboa

14h00 – 15h30 | Bremen Auditorium, Hall 6.2 | “Why we need to move beyond ICB? Sensitivity and resistance to the available ICB options”, Inês Pires da Silva, Melanoma Institute Australia, Wollstonecraft, AU

14h00-15h30 | Nuremberg Auditorium, Hall 5.2 | “1520MO - Phase I first-in-human study of a novel anti-CD137 switch antibody agonist STA551 (STA) as monotherapy and in combination with atezolizumab (atezo) in patients (pts) with advanced solid tumors”, Diogo Silva, The Institute of Cancer Research and Royal Marsden Hospital, Sutton, GB

14h00- 15h30 | Karlsruhe Auditorium, Hall 5.2 | “Methylation profiling of peripheral immune cells”, Daniel de Carvalho, Princess Margaret Cancer Centre, Toronto, CA

16h00 – 17h30 | Bonn Auditorium, Hall 7.1c | “Stage I germ cell tumours: Controversies and biomarkers”, Ricardo Leão, CUF Coimbra Hospital (fala entre as 16h20 e as 16h40)

18 de outubro:

08h30 – 10h00 | Cologne Auditorium, CityCube A | “117MO - Clinical and multi-omics predictive model of resistance to neoadjuvant anti-PD1 (PD1) in melanoma”, Inês Pires Da Silva, Melanoma Institute Australia, Wollstonecraft, AU

08h30 – 10h00 | Bochum Auditorium, Hall 6.1 | “ECHoS – Establishing National Cancer Mission Hubs”, Anabela Isidro, AICIB – Agência de investigação Clínica e Inovação Biomédica, Porto (fala entre as 08h50 e as 09h10)

11h30 – 12h30 | Erfurt Auditorium, CityCube A | “Mentor the Mentor session”, Teresa Amaral, skin cancer clinical trials center, University of Tuebingen, DE

16h45 – 18h00 | Potsdam Auditorium, Hall 5.1 | “Type: EONS session”, Ana Rita Teixeira Sousa

19 de outubro

08h30 – 10h00 | Bochum Auditorium, Hall 6.1 | “The current “non-operational” trial challegenge: Tackling bureaucracy and over regulation”, Teresa Amaral, skin cancer clinical trials center, University of Tuebingen, DE

10h15 – 11h45 | Bonn Auditorium, Hall 7.1c | “Cutaneous melanoma: discussion”, Teresa Amaral, skin cancer clinical trials center, University of Tuebingen, DE

16h30 – 18h00 | Hamburg Auditorium, CityCube A | “Young Patients”, Fátima Cardoso, ABC Global Alliance, Lisboa

18h30 – 20h00 | Karlsruhe Auditorium, Hall 5.2 | “Challenge #2: mCRPC with an HRR mutation”, Pedro Barata, University Hospitals Seidman Cancer Center, Cleveland

20 de outubro

08h30 – 10h00 | Dortmund Auditorium, Hall 7.1a | “Proffered paper session: melanoma and other skin tumours”, Inês Pires da Silva, Melanoma Institute Australia, Wollstonecraft, AU

13h00 – 14h30 | Erfurt Auditorium, CityCube A | “Fellowships in Europe: Educational opportunities for Young Oncologists”, Teresa Amaral, Skin Cancer Clinical Trials Center, University of Tuebingen, Tübingen, DE